middle.news
ResMed Delivers 10% Revenue Growth and 52% Operating Profit Surge in Q2 FY2025
8:22am on Friday 31st of January, 2025 AEDT
•
Healthcare
Read Story
ResMed Delivers 10% Revenue Growth and 52% Operating Profit Surge in Q2 FY2025
8:22am on Friday 31st of January, 2025 AEDT
Key Points
10% year-over-year revenue growth to $1.3 billion
52% increase in GAAP operating profit; 19% rise in non-GAAP operating profit
Gross margin improved by 300 basis points to 58.6%
Operating cash flow reached $309 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE